The UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback